BuzzSparks.org

Cardioxyl Pharmaceuticals


Clinical stage biopharmaceutical company

Cardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and commercialization of novel technologies for disease...

Founded in 2005
Homepage:
Total money raised: $57.5M

27517 Exchange East, Suite 212
1450 Raleigh Road

Chapel Hill
Chapel Hill
USA NC

Phone: (919) 869-8585

Christopher A. Kroeger President and CEO
John Reardon Chief Scientific Officer
Robert Garland director
M. James Barrett Board Member
Past

November, 2012

Cardioxyl Pharmaceuticals raised $28M in a Series B round from OrbiMed Advisors, New Enterprise Associates, The Aurora Funds, and Osage University Partners

Cardioxyl Pharmaceuticals Raises $28 Million in Series B Financing Led by OrbiMed Advisors    cardioxyl.com

August, 2010

Cardioxyl Pharmaceuticals raised $15M in unattributed round

SEC    sec.gov

December, 2006

Cardioxyl Pharmaceuticals raised $14.5M in a Series A round from The Aurora Funds and New Enterprise Associates

Cardioxyl Raises 14.5MM Series A Financing    cardioxyl.com

2005

Cardioxyl Pharmaceuticals was founded in 2005